Genomic and phenotypic insights from an atlas of genetic effects on DNA methylation.


Journal

Nature genetics
ISSN: 1546-1718
Titre abrégé: Nat Genet
Pays: United States
ID NLM: 9216904

Informations de publication

Date de publication:
09 2021
Historique:
received: 13 10 2020
accepted: 12 07 2021
entrez: 8 9 2021
pubmed: 9 9 2021
medline: 15 10 2021
Statut: ppublish

Résumé

Characterizing genetic influences on DNA methylation (DNAm) provides an opportunity to understand mechanisms underpinning gene regulation and disease. In the present study, we describe results of DNAm quantitative trait locus (mQTL) analyses on 32,851 participants, identifying genetic variants associated with DNAm at 420,509 DNAm sites in blood. We present a database of >270,000 independent mQTLs, of which 8.5% comprise long-range (trans) associations. Identified mQTL associations explain 15-17% of the additive genetic variance of DNAm. We show that the genetic architecture of DNAm levels is highly polygenic. Using shared genetic control between distal DNAm sites, we constructed networks, identifying 405 discrete genomic communities enriched for genomic annotations and complex traits. Shared genetic variants are associated with both DNAm levels and complex diseases, but only in a minority of cases do these associations reflect causal relationships from DNAm to trait or vice versa, indicating a more complex genotype-phenotype map than previously anticipated.

Identifiants

pubmed: 34493871
doi: 10.1038/s41588-021-00923-x
pii: 10.1038/s41588-021-00923-x
pmc: PMC7612069
mid: EMS131971
doi:

Substances chimiques

DNA 9007-49-2

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1311-1321

Subventions

Organisme : ZonMw
ID : ZONMW_529051021
Pays : Netherlands
Organisme : Medical Research Council
ID : MC_UU_00006/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/L501529/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_PC_21038
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 204979/Z/16/Z
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/M008924/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_UU_00006/2
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_UU_12015/2
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/N024397/1
Pays : United Kingdom
Organisme : British Heart Foundation
ID : CS/15/6/31468
Pays : United Kingdom
Organisme : British Heart Foundation
ID : CS/13/1/30327
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_UU_00011/5
Pays : United Kingdom
Organisme : Medical Research Council
ID : G1001357
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_PC_19009
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/K013807/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_PC_15018
Pays : United Kingdom
Organisme : Motor Neurone Disease Association
ID : ALCHALABI-TALBOT/APR14/926-794
Pays : United Kingdom
Organisme : Medical Research Council
ID : G1002190
Pays : United Kingdom
Organisme : Medical Research Council
ID : G0600974
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/R024804/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_UU_00007/10
Pays : United Kingdom
Organisme : British Heart Foundation
ID : CS/16/4/32482
Pays : United Kingdom
Organisme : Cancer Research UK
ID : A19169
Pays : United Kingdom
Organisme : Motor Neurone Disease Association
ID : ALCHALABI-DOBSON/APR14/829-791
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_UU_00011/4
Pays : United Kingdom
Organisme : Cancer Research UK (CRUK)
ID : C18281/A191169
Organisme : Wellcome Trust
ID : 208806
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_UU_12013/8
Pays : United Kingdom
Organisme : Medical Research Council
ID : G9815508
Pays : United Kingdom
Organisme : Biotechnology and Biological Sciences Research Council
ID : BB/S020845/1
Pays : United Kingdom
Organisme : Wellcome Trust
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 208806/Z/17/Z
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/R005176/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_UU_00011/1
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 204979
Pays : United Kingdom

Informations de copyright

© 2021. The Author(s), under exclusive licence to Springer Nature America, Inc.

Références

Petronis, A. Epigenetics as a unifying principle in the aetiology of complex traits and diseases. Nature 465, 721–727 (2010).
pubmed: 20535201 doi: 10.1038/nature09230
van Dongen, J. et al. Genetic and environmental influences interact with age and sex in shaping the human methylome. Nat. Commun. 7, 11115 (2016).
pubmed: 27051996 pmcid: 4820961 doi: 10.1038/ncomms11115
Hannon, E. et al. Characterizing genetic and environmental influences on variable DNA methylation using monozygotic and dizygotic twins. PLoS Genet. 14, e1007544 (2018).
pubmed: 30091980 pmcid: 6084815 doi: 10.1371/journal.pgen.1007544
Kerkel, K. et al. Genomic surveys by methylation-sensitive SNP analysis identify sequence-dependent allele-specific DNA methylation. Nat. Genet. 40, 904–908 (2008).
pubmed: 18568024 doi: 10.1038/ng.174
Schadt, E. E. et al. Genetics of gene expression surveyed in maize, mouse and man. Nature 422, 297–302 (2003).
pubmed: 12646919 doi: 10.1038/nature01434
Davey Smith, G. & Hemani, G. Mendelian randomization: genetic anchors for causal inference in epidemiological studies. Hum. Mol. Genet. 23, R89–R98 (2014).
pubmed: 25064373 pmcid: 4170722 doi: 10.1093/hmg/ddu328
Gaunt, T. R. et al. Systematic identification of genetic influences on methylation across the human life course. Genome Biol. 17, 61 (2016).
pubmed: 27036880 pmcid: 4818469 doi: 10.1186/s13059-016-0926-z
Bonder, M. J. et al. Disease variants alter transcription factor levels and methylation of their binding sites. Nat. Genet. 49, 131–138 (2017).
pubmed: 27918535 doi: 10.1038/ng.3721
Hannon, E. et al. Methylation QTLs in the developing brain and their enrichment in schizophrenia risk loci. Nat. Neurosci. 19, 48–54 (2016).
pubmed: 26619357 doi: 10.1038/nn.4182
Hop, P. J. et al. Genome-wide identification of genes regulating DNA methylation using genetic anchors for causal inference. Genome Biol. 21, 220 (2020).
pubmed: 32859263 pmcid: 7453518 doi: 10.1186/s13059-020-02114-z
Abecasis, G. R. et al. An integrated map of genetic variation from 1,092 human genomes. Nature 491, 56–65 (2012).
pubmed: 23128226 doi: 10.1038/nature11632
Pidsley, R. et al. Critical evaluation of the Illumina MethylationEPIC BeadChip microarray for whole-genome DNA methylation profiling. Genome Biol. 17, 208 (2016).
pubmed: 27717381 pmcid: 5055731 doi: 10.1186/s13059-016-1066-1
Bibikova, M. et al. High density DNA methylation array with single CpG site resolution. Genomics 98, 288–295 (2011).
pubmed: 21839163 doi: 10.1016/j.ygeno.2011.07.007
Yang, J. et al. Conditional and joint multiple-SNP analysis of GWAS summary statistics identifies additional variants influencing complex traits. Nat. Genet. 44, 369–375 (2012).
pubmed: 22426310 pmcid: 3593158 doi: 10.1038/ng.2213
Shah, S. et al. Genetic and environmental exposures constrain epigenetic drift over the human life course. Genome Res. 24, 1725–1733 (2014).
pubmed: 25249537 pmcid: 4216914 doi: 10.1101/gr.176933.114
Gutierrez-Arcelus, M. et al. Passive and active DNA methylation and the interplay with genetic variation in gene regulation. Elife 2, e00523 (2013).
pubmed: 23755361 pmcid: 3673336 doi: 10.7554/eLife.00523
Chen, L. et al. Genetic drivers of epigenetic and transcriptional variation in human immune cells. Cell 167, 1398–1414.e24 (2016).
pubmed: 27863251 pmcid: 5119954 doi: 10.1016/j.cell.2016.10.026
McRae, A. F. et al. Identification of 55,000 replicated DNA methylation QTL. Sci. Rep. 8, 17605 (2018).
pubmed: 30514905 pmcid: 6279736 doi: 10.1038/s41598-018-35871-w
Kundaje, A. et al. Integrative analysis of 111 reference human epigenomes. Nature 518, 317–330 (2015).
pubmed: 25693563 pmcid: 4530010 doi: 10.1038/nature14248
Wahl, S. et al. Epigenome-wide association study of body mass index, and the adverse outcomes of adiposity. Nature 541, 81–86 (2017).
pubmed: 28002404 doi: 10.1038/nature20784
Elliott, G. et al. Intermediate DNA methylation is a conserved signature of genome regulation. Nat. Commun. 6, 6363 (2015).
pubmed: 25691127 doi: 10.1038/ncomms7363
Feldmann, A. et al. Transcription factor occupancy can mediate active turnover of DNA methylation at regulatory regions. PLoS Genet. 9, e1003994 (2013).
pubmed: 24367273 pmcid: 3868540 doi: 10.1371/journal.pgen.1003994
Grundberg, E. et al. Global analysis of DNA methylation variation in adipose tissue from twins reveals links to disease-associated variants in distal regulatory elements. Am. J. Hum. Genet. 93, 876–890 (2013).
pubmed: 24183450 pmcid: 3824131 doi: 10.1016/j.ajhg.2013.10.004
Kim-Hellmuth, S. et al. Cell type-specific genetic regulation of gene expression across human tissues. Science 369, eaaz8528 (2020).
pubmed: 32913075 pmcid: 8051643 doi: 10.1126/science.aaz8528
Qi, T. et al. Identifying gene targets for brain-related traits using transcriptomic and methylomic data from blood. Nat. Commun. 9, 2282 (2018).
pubmed: 29891976 pmcid: 5995828 doi: 10.1038/s41467-018-04558-1
Yin, Y. et al. Impact of cytosine methylation on DNA binding specificities of human transcription factors. Science 356, eaaj2239 (2017).
pubmed: 28473536 pmcid: 8009048 doi: 10.1126/science.aaj2239
Domcke, S. et al. Competition between DNA methylation and transcription factors determines binding of NRF1. Nature 528, 575–579 (2015).
pubmed: 26675734 doi: 10.1038/nature16462
Baubec, T. et al. Genomic profiling of DNA methyltransferases reveals a role for DNMT3B in genic methylation. Nature 520, 243–247 (2015).
pubmed: 25607372 doi: 10.1038/nature14176
Ginno, P. A. et al. A genome-scale map of DNA methylation turnover identifies site-specific dependencies of DNMT and TET activity. Nat. Commun. 11, 2680 (2020).
pubmed: 32471981 pmcid: 7260214 doi: 10.1038/s41467-020-16354-x
Sánchez-Castillo, M. et al. CODEX: a next-generation sequencing experiment database for the haematopoietic and embryonic stem cell communities. Nucleic Acids Res. 43, D1117–D1123 (2015).
pubmed: 25270877 doi: 10.1093/nar/gku895
ENCODE Project Consortium. An integrated encyclopedia of DNA elements in the human genome. Nature 489, 57–74 (2012).
Waszak, S. M. et al. Population variation and genetic control of modular chromatin architecture in humans. Cell 162, 1039–1050 (2015).
pubmed: 26300124 doi: 10.1016/j.cell.2015.08.001
Viny, A. D. et al. Dose-dependent role of the cohesin complex in normal and malignant hematopoiesis. J. Exp. Med. 212, 1819–1832 (2015).
pubmed: 26438361 pmcid: 4612085 doi: 10.1084/jem.20151317
Battle, A. et al. Genetic effects on gene expression across human tissues. Nature 550, 204–213 (2017).
pubmed: 29022597 doi: 10.1038/nature24277
Kumasaka, N., Knights, A. J. & Gaffney, D. J. High-resolution genetic mapping of putative causal interactions between regions of open chromatin. Nat. Genet. 51, 128–137 (2019).
pubmed: 30478436 doi: 10.1038/s41588-018-0278-6
Rao, S. S. et al. A 3D map of the human genome at kilobase resolution reveals principles of chromatin looping. Cell 159, 1665–1680 (2014).
pubmed: 25497547 pmcid: 5635824 doi: 10.1016/j.cell.2014.11.021
Delaneau, O. et al. Chromatin three-dimensional interactions mediate genetic effects on gene expression. Science 364, eaat8266 (2019).
pubmed: 31048460 doi: 10.1126/science.aat8266
Võsa, U. et al. Large-scale cis- and trans-eQTL analyses identify thousands of genetic loci and polygenic scores that regulate blood gene expression. Nat. Genet. https://doi.org/10.1038/s41588-021-00913-z (2021).
Astle, W. J. et al. The allelic landscape of human blood cell trait variation and links to common complex disease. Cell 167, 1415–1429.e19 (2016).
pubmed: 27863252 pmcid: 5300907 doi: 10.1016/j.cell.2016.10.042
Maurano, M. T. et al. Systematic localization of common disease-associated variation in regulatory DNA. Science 337, 1190–1195 (2012).
pubmed: 22955828 pmcid: 3771521 doi: 10.1126/science.1222794
Tachmazidou, I. et al. Whole-genome sequencing coupled to imputation discovers genetic signals for anthropometric traits. Am. J. Hum. Genet. 100, 865–884 (2017).
pubmed: 28552196 pmcid: 5473732 doi: 10.1016/j.ajhg.2017.04.014
Kato, N. et al. Trans-ancestry genome-wide association study identifies 12 genetic loci influencing blood pressure and implicates a role for DNA methylation. Nat. Genet. 47, 1282–1293 (2015).
pubmed: 26390057 pmcid: 4719169 doi: 10.1038/ng.3405
Iotchkova, V. et al. GARFIELD classifies disease-relevant genomic features through integration of functional annotations with association signals. Nat. Genet. 51, 343–353 (2019).
pubmed: 30692680 pmcid: 6908448 doi: 10.1038/s41588-018-0322-6
Finucane, H. K. et al. Partitioning heritability by functional annotation using genome-wide association summary statistics. Nat. Genet. 47, 1228–1235 (2015).
pubmed: 26414678 pmcid: 4626285 doi: 10.1038/ng.3404
Reinius, L. E. et al. Differential DNA methylation in purified human blood cells: implications for cell lineage and studies on disease susceptibility. PLoS ONE 7, e41361 (2012).
pubmed: 22848472 pmcid: 3405143 doi: 10.1371/journal.pone.0041361
Houseman, E. A. et al. Model-based clustering of DNA methylation array data: a recursive-partitioning algorithm for high-dimensional data arising as a mixture of beta distributions. BMC Bioinform. 9, 365 (2008).
doi: 10.1186/1471-2105-9-365
Hemani, G., Tilling, K. & Davey Smith, G. Orienting the causal relationship between imprecisely measured traits using GWAS summary data. PLoS Genet. 13, e1007081 (2017).
pubmed: 29149188 pmcid: 5711033 doi: 10.1371/journal.pgen.1007081
Giambartolomei, C. et al. Bayesian test for colocalisation between pairs of genetic association studies using summary statistics. PLoS Genet. 10, e1004383 (2014).
pubmed: 24830394 pmcid: 4022491 doi: 10.1371/journal.pgen.1004383
Zhu, Z. et al. Integration of summary data from GWAS and eQTL studies predicts complex trait gene targets. Nat. Genet. 48, 481–487 (2016).
pubmed: 27019110 doi: 10.1038/ng.3538
Zheng, J. et al. Phenome-wide Mendelian randomization mapping the influence of the plasma proteome on complex diseases. Nat Genet. 52, 1122–1131 (2020).
pubmed: 32895551 pmcid: 7610464 doi: 10.1038/s41588-020-0682-6
Richardson, T. G. et al. Systematic Mendelian randomization framework elucidates hundreds of CpG sites which may mediate the influence of genetic variants on disease. Hum. Mol. Genet. 27, 3293–3304 (2018).
pubmed: 29893838 pmcid: 6121186 doi: 10.1093/hmg/ddy210
Hemani, G., Bowden, J. & Davey Smith, G. Evaluating the potential role of pleiotropy in Mendelian randomization studies. Hum. Mol. Genet. 27, R195–R208 (2018).
pubmed: 29771313 pmcid: 6061876 doi: 10.1093/hmg/ddy163
Brion, M. J., Shakhbazov, K. & Visscher, P. M. Calculating statistical power in Mendelian randomization studies. Int. J. Epidemiol. 42, 1497–1501 (2013).
pubmed: 24159078 doi: 10.1093/ije/dyt179
Pierce, B. L. & Burgess, S. Efficient design for Mendelian randomization studies: subsample and 2-sample instrumental variable estimators. Am. J. Epidemiol. 178, 1177–1184 (2013).
pubmed: 23863760 pmcid: 3783091 doi: 10.1093/aje/kwt084
Hemani, G. et al. The MR-base platform supports systematic causal inference across the human phenome. Elife 7, e34408 (2018).
pubmed: 29846171 pmcid: 5976434 doi: 10.7554/eLife.34408
Dekkers, K. F. et al. Blood lipids influence DNA methylation in circulating cells. Genome Biol. 17, 138 (2016).
pubmed: 27350042 pmcid: 4922056 doi: 10.1186/s13059-016-1000-6
Braun, K. V. E. et al. Epigenome-wide association study (EWAS) on lipids: the Rotterdam study. Clin. Epigenet. 9, 15 (2017).
doi: 10.1186/s13148-016-0304-4
Simpson, J. T. et al. Detecting DNA cytosine methylation using nanopore sequencing. Nat. Methods 14, 407–410 (2017).
pubmed: 28218898 doi: 10.1038/nmeth.4184
Zhou, W., Laird, P. W. & Shen, H. Comprehensive characterization, annotation and innovative use of Infinium DNA methylation BeadChip probes. Nucleic Acids Res. 45, e22 (2017).
pubmed: 27924034
Winkler, T. W. et al. Quality control and conduct of genome-wide association meta-analyses. Nat. Protoc. 9, 1192–1212 (2014).
pubmed: 24762786 pmcid: 4083217 doi: 10.1038/nprot.2014.071
Chang, C. C. et al. Second-generation PLINK: rising to the challenge of larger and richer datasets. Gigascience 4, 7 (2015).
pubmed: 25722852 pmcid: 4342193 doi: 10.1186/s13742-015-0047-8
Conomos, M. P., Reiner, A. P., Weir, B. S. & Thornton, T. A. Model-free estimation of recent genetic relatedness. Am. J. Hum. Genet. 98, 127–148 (2016).
pubmed: 26748516 pmcid: 4716688 doi: 10.1016/j.ajhg.2015.11.022
Min, J. L., Hemani, G., Davey Smith, G., Relton, C. & Suderman, M. Meffil: efficient normalization and analysis of very large DNA methylation datasets. Bioinformatics 34, 3983–3989 (2018).
pubmed: 29931280 pmcid: 6247925 doi: 10.1093/bioinformatics/bty362
Zeilinger, S. et al. Tobacco smoking leads to extensive genome-wide changes in DNA methylation. PLoS ONE 8, e63812 (2013).
pubmed: 23691101 pmcid: 3656907 doi: 10.1371/journal.pone.0063812
Aulchenko, Y. S., de Koning, D. J. & Haley, C. Genomewide rapid association using mixed model and regression: a fast and simple method for genomewide pedigree-based quantitative trait loci association analysis. Genetics 177, 577–585 (2007).
pubmed: 17660554 pmcid: 2013682 doi: 10.1534/genetics.107.075614
Chen, Y. A. et al. Discovery of cross-reactive probes and polymorphic CpGs in the Illumina Infinium HumanMethylation450 microarray. Epigenetics 8, 203–209 (2013).
pubmed: 23314698 pmcid: 3592906 doi: 10.4161/epi.23470
Naeem, H. et al. Reducing the risk of false discovery enabling identification of biologically significant genome-wide methylation status using the HumanMethylation450 array. BMC Genom. 15, 51 (2014).
doi: 10.1186/1471-2164-15-51
Price, M. E. et al. Additional annotation enhances potential for biologically-relevant analysis of the Illumina Infinium HumanMethylation450 BeadChip array. Epigenet. Chromatin 6, 4 (2013).
doi: 10.1186/1756-8935-6-4
Shabalin, A. A. Matrix eQTL: ultra fast eQTL analysis via large matrix operations. Bioinformatics 28, 1353–1358 (2012).
pubmed: 22492648 pmcid: 3348564 doi: 10.1093/bioinformatics/bts163
Dahl, A., Guillemot, V., Mefford, J., Aschard, H. & Zaitlen, N. Adjusting for principal components of molecular phenotypes induces replicating false positives. Genetics 211, 1179–1189 (2019).
pubmed: 30692194 pmcid: 6456307 doi: 10.1534/genetics.118.301768
Willer, C. J., Li, Y. & Abecasis, G. R. METAL: fast and efficient meta-analysis of genomewide association scans. Bioinformatics 26, 2190–2191 (2010).
pubmed: 20616382 pmcid: 2922887 doi: 10.1093/bioinformatics/btq340
DerSimonian, R. & Laird, N. Meta-analysis in clinical trials. Control Clin. Trials 7, 177–188 (1986).
pubmed: 3802833 doi: 10.1016/0197-2456(86)90046-2
Hedges, L. V. & Olkin, I. Statistical Methods for Meta-Analysis 189–203 (Academic Press, 1985).

Auteurs

Josine L Min (JL)

MRC Integrative Epidemiology Unit, University of Bristol, Bristol, UK. josine.min@bristol.ac.uk.
Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK. josine.min@bristol.ac.uk.

Gibran Hemani (G)

MRC Integrative Epidemiology Unit, University of Bristol, Bristol, UK.
Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK.

Eilis Hannon (E)

University of Exeter Medical School, College of Medicine and Health, University of Exeter, Exeter, UK.

Koen F Dekkers (KF)

Molecular Epidemiology, Department of Biomedical Data Sciences, Leiden University Medical Center, Leiden, the Netherlands.

Juan Castillo-Fernandez (J)

Department of Twin Research and Genetic Epidemiology, King's College London, London, UK.

René Luijk (R)

Molecular Epidemiology, Department of Biomedical Data Sciences, Leiden University Medical Center, Leiden, the Netherlands.

Elena Carnero-Montoro (E)

Department of Twin Research and Genetic Epidemiology, King's College London, London, UK.
Pfizer-University of Granada-Andalusian Government Center for Genomics and Oncological Research, Granada, Spain.

Daniel J Lawson (DJ)

MRC Integrative Epidemiology Unit, University of Bristol, Bristol, UK.
Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK.

Kimberley Burrows (K)

MRC Integrative Epidemiology Unit, University of Bristol, Bristol, UK.
Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK.

Matthew Suderman (M)

MRC Integrative Epidemiology Unit, University of Bristol, Bristol, UK.
Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK.

Andrew D Bretherick (AD)

MRC Human Genetics Unit, Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh, UK.

Tom G Richardson (TG)

MRC Integrative Epidemiology Unit, University of Bristol, Bristol, UK.
Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK.

Johanna Klughammer (J)

CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria.

Valentina Iotchkova (V)

MRC Weatherall Institute of Molecular Medicine, Oxford, UK.

Gemma Sharp (G)

MRC Integrative Epidemiology Unit, University of Bristol, Bristol, UK.
Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK.

Ahmad Al Khleifat (A)

Department of Basic and Clinical Neuroscience, Maurice Wohl Clinical Neuroscience Institute, London, UK.

Aleksey Shatunov (A)

Department of Basic and Clinical Neuroscience, Maurice Wohl Clinical Neuroscience Institute, London, UK.

Alfredo Iacoangeli (A)

Department of Basic and Clinical Neuroscience, Maurice Wohl Clinical Neuroscience Institute, London, UK.
Department of Biostatistics and Health Informatics, King's College London, London, UK.

Wendy L McArdle (WL)

Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK.

Karen M Ho (KM)

Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK.

Ashish Kumar (A)

Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.
Chronic Disease Epidemiology unit, Swiss Tropical and Public Health Institute, Basel, Switzerland.
University of Basel, Basel, Switzerland.

Cilla Söderhäll (C)

Department of Women's and Children's Health, Karolinska Institutet, Stockholm, Sweden.

Carolina Soriano-Tárraga (C)

Neurology Department, Hospital del Mar, Institut Hospital del Mar d'Investigacions Mèdiques, Barcelona, Spain.

Eva Giralt-Steinhauer (E)

Neurology Department, Hospital del Mar, Institut Hospital del Mar d'Investigacions Mèdiques, Barcelona, Spain.

Nabila Kazmi (N)

MRC Integrative Epidemiology Unit, University of Bristol, Bristol, UK.
Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK.

Dan Mason (D)

Bradford Institute for Health Research, Bradford, UK.

Allan F McRae (AF)

Institute for Molecular Bioscience, University of Queensland, Brisbane, Australia.

David L Corcoran (DL)

Center for Genomic and Computational Biology, Duke University, Durham, NC, USA.

Karen Sugden (K)

Center for Genomic and Computational Biology, Duke University, Durham, NC, USA.
Department of Psychology and Neuroscience, Duke University, Durham, NC, USA.

Silva Kasela (S)

Estonian Genome Center, Institute of Genomics, University of Tartu, Tartu, Estonia.

Alexia Cardona (A)

MRC Epidemiology Unit, School of Clinical Medicine, Institute of Metabolic Science, University of Cambridge, Cambridge, UK.
Department of Genetics, University of Cambridge, Cambridge, UK.

Felix R Day (FR)

MRC Epidemiology Unit, School of Clinical Medicine, Institute of Metabolic Science, University of Cambridge, Cambridge, UK.

Giovanni Cugliari (G)

Department of Medical Sciences, University of Turin, Turin, Italy.
Italian Institute for Genomic Medicine, Turin, Italy.

Clara Viberti (C)

Department of Medical Sciences, University of Turin, Turin, Italy.
Italian Institute for Genomic Medicine, Turin, Italy.

Simonetta Guarrera (S)

Department of Medical Sciences, University of Turin, Turin, Italy.
Italian Institute for Genomic Medicine, Turin, Italy.

Michael Lerro (M)

Dalla Lana School of Public Health, University of Toronto, Toronto, Canada.

Richa Gupta (R)

Institute for Molecular Medicine, University of Helsinki, Helsinki, Finland.
Department of Public Health, Faculty of Medicine, University of Helsinki, Helsinki, Finland.

Sailalitha Bollepalli (S)

Institute for Molecular Medicine, University of Helsinki, Helsinki, Finland.
Department of Public Health, Faculty of Medicine, University of Helsinki, Helsinki, Finland.

Pooja Mandaviya (P)

Department of Internal Medicine, Erasmus University Medical Center, Rotterdam, the Netherlands.

Yanni Zeng (Y)

MRC Human Genetics Unit, Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh, UK.
Faculty of Forensic Medicine, Zhongshan School of Medicine, Sun Yat-Sen University, Guangzhou, China.
Guangdong Province Key Laboratory of Brain Function and Disease, Zhongshan School of Medicine, Sun Yat-Sen University, Guangzhou, China.

Toni-Kim Clarke (TK)

Division of Psychiatry, Royal Edinburgh Hospital, University of Edinburgh, Edinburgh, UK.

Rosie M Walker (RM)

Centre for Genomic and Experimental Medicine, Institute of Genetics and Molecular Medicine, Western General Hospital, University of Edinburgh, Edinburgh, UK.
Centre for Cognitive Ageing and Cognitive Epidemiology, Department of Psychology, University of Edinburgh, Edinburgh, UK.

Vanessa Schmoll (V)

Department of Translational Research in Psychiatry, Max-Planck-Institute of Psychiatry, Munich, Germany.

Darina Czamara (D)

Department of Translational Research in Psychiatry, Max-Planck-Institute of Psychiatry, Munich, Germany.

Carlos Ruiz-Arenas (C)

ISGlobal, Barcelona Global Health Institute, Barcelona, Spain.
Universitat Pompeu Fabra, Barcelona, Spain.
CIBER Epidemiología y Salud Pública, Madrid, Spain.

Faisal I Rezwan (FI)

Department of Computer Science, Aberystwyth University, Aberystwyth, UK.

Riccardo E Marioni (RE)

Centre for Genomic and Experimental Medicine, Institute of Genetics and Molecular Medicine, Western General Hospital, University of Edinburgh, Edinburgh, UK.
Centre for Cognitive Ageing and Cognitive Epidemiology, Department of Psychology, University of Edinburgh, Edinburgh, UK.

Tian Lin (T)

Institute for Molecular Bioscience, University of Queensland, Brisbane, Australia.

Yvonne Awaloff (Y)

Department of Translational Research in Psychiatry, Max-Planck-Institute of Psychiatry, Munich, Germany.

Marine Germain (M)

INSERM UMR_S 1219, Bordeaux Population Health Center, University of Bordeaux, Bordeaux, France.

Dylan Aïssi (D)

Department of General and Interventional Cardiology, University Heart Center Hamburg, Hamburg, Germany.

Ramona Zwamborn (R)

Department of Neurology, Brain Center Rudolf Magnus, University Medical Center Utrecht, Utrecht, the Netherlands.

Kristel van Eijk (K)

Department of Neurology, Brain Center Rudolf Magnus, University Medical Center Utrecht, Utrecht, the Netherlands.

Annelot Dekker (A)

Department of Neurology, Brain Center Rudolf Magnus, University Medical Center Utrecht, Utrecht, the Netherlands.

Jenny van Dongen (J)

Department of Biological Psychology, Amsterdam Public Health Research Institute, Vrije Universiteit Amsterdam, Amsterdam, the Netherlands.

Jouke-Jan Hottenga (JJ)

Department of Biological Psychology, Amsterdam Public Health Research Institute, Vrije Universiteit Amsterdam, Amsterdam, the Netherlands.

Gonneke Willemsen (G)

Department of Biological Psychology, Amsterdam Public Health Research Institute, Vrije Universiteit Amsterdam, Amsterdam, the Netherlands.

Cheng-Jian Xu (CJ)

University of Groningen, University Medical Center Groningen, Department of Pediatric Pulmonology and Pediatric Allergology, Beatrix Children's Hospital, GRIAC Research Institute Groningen, Groningen, the Netherlands.
CiiM and TWINCORE, Hannover Medical School and Helmholtz Centre for Infection Research, Hannover, Germany.

Guillermo Barturen (G)

Pfizer-University of Granada-Andalusian Government Center for Genomics and Oncological Research, Granada, Spain.

Francesc Català-Moll (F)

Chromatin and Disease Group, Cancer Epigenetics and Biology Programme, Bellvitge Biomedical Research Institute, Barcelona, Spain.

Martin Kerick (M)

Instituto de Parasitología y Biomedicina López Neyra, CSIC, Granada, Spain.

Carol Wang (C)

School of Medicine and Public Health, College of Health, Medicine and Wellbeing, University of Newcastle, Newcastle, Australia.

Phillip Melton (P)

Menzies Institute for Medical Research, College of Health and Medicine, University of Tasmania, Hobart, Australia.
School of Global Population Health, Faculty of Health and Medical Sciences, University of Western Australia, Perth, Australia.
School of Pharmacy and Biomedical Sciences, Faculty of Health Sciences, Curtin University, Perth, Australia.

Hannah R Elliott (HR)

MRC Integrative Epidemiology Unit, University of Bristol, Bristol, UK.
Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK.

Jean Shin (J)

The Hospital for Sick Children, University of Toronto, Toronto, Canada.

Manon Bernard (M)

The Hospital for Sick Children, University of Toronto, Toronto, Canada.

Idil Yet (I)

Department of Twin Research and Genetic Epidemiology, King's College London, London, UK.
Department of Bioinformatics, Institute of Health Sciences, Hacettepe University, Ankara, Turkey.

Melissa Smart (M)

Institute for Social and Economic Research, University of Essex, Colchester, UK.

Tyler Gorrie-Stone (T)

School of Life Sciences, University of Essex, Colchester, UK.

Chris Shaw (C)

Department of Basic and Clinical Neuroscience, Maurice Wohl Clinical Neuroscience Institute, London, UK.
Department of Neurology, King's College Hospital, London, UK.

Ammar Al Chalabi (A)

Department of Basic and Clinical Neuroscience, Maurice Wohl Clinical Neuroscience Institute, London, UK.
Department of Neurology, King's College Hospital, London, UK.
United Kingdom Dementia Research Institute, King's College London, London, UK.

Susan M Ring (SM)

MRC Integrative Epidemiology Unit, University of Bristol, Bristol, UK.
Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK.

Göran Pershagen (G)

Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.

Erik Melén (E)

Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.
Department of Clinical Science and Education, Södersjukhuset, Karolinska Institutet, Stockholm, Sweden.

Jordi Jiménez-Conde (J)

Neurology Department, Hospital del Mar, Institut Hospital del Mar d'Investigacions Mèdiques, Barcelona, Spain.

Jaume Roquer (J)

Neurology Department, Hospital del Mar, Institut Hospital del Mar d'Investigacions Mèdiques, Barcelona, Spain.

Deborah A Lawlor (DA)

MRC Integrative Epidemiology Unit, University of Bristol, Bristol, UK.
Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK.

John Wright (J)

Bradford Institute for Health Research, Bradford, UK.

Nicholas G Martin (NG)

QIMR Berghofer Medical Research Institute, Brisbane, Australia.

Grant W Montgomery (GW)

Institute for Molecular Bioscience, University of Queensland, Brisbane, Australia.

Terrie E Moffitt (TE)

Center for Genomic and Computational Biology, Duke University, Durham, NC, USA.
Department of Psychology and Neuroscience, Duke University, Durham, NC, USA.
Department of Psychiatry and Behavioral Sciences, Duke University Medical School, Durham, NC, USA.
Social, Genetic and Developmental Psychiatry Centre, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.

Richie Poulton (R)

Dunedin Multidisciplinary Health and Development Research Unit, Department of Psychology, University of Otago, Dunedin, New Zealand.

Tõnu Esko (T)

Estonian Genome Center, Institute of Genomics, University of Tartu, Tartu, Estonia.
Program in Medical and Population Genetics, Broad Institute, Cambridge, MA, USA.

Lili Milani (L)

Estonian Genome Center, Institute of Genomics, University of Tartu, Tartu, Estonia.

Andres Metspalu (A)

Estonian Genome Center, Institute of Genomics, University of Tartu, Tartu, Estonia.

John R B Perry (JRB)

MRC Epidemiology Unit, School of Clinical Medicine, Institute of Metabolic Science, University of Cambridge, Cambridge, UK.

Ken K Ong (KK)

MRC Epidemiology Unit, School of Clinical Medicine, Institute of Metabolic Science, University of Cambridge, Cambridge, UK.

Nicholas J Wareham (NJ)

MRC Epidemiology Unit, School of Clinical Medicine, Institute of Metabolic Science, University of Cambridge, Cambridge, UK.

Giuseppe Matullo (G)

Department of Medical Sciences, University of Turin, Turin, Italy.
Italian Institute for Genomic Medicine, Turin, Italy.

Carlotta Sacerdote (C)

Italian Institute for Genomic Medicine, Turin, Italy.
Piemonte Centre for Cancer Prevention, Turin, Italy.

Salvatore Panico (S)

Dipartimento Di Medicina Clinica E Chirurgia, Federico II University, Naples, Italy.

Avshalom Caspi (A)

Center for Genomic and Computational Biology, Duke University, Durham, NC, USA.
Department of Psychology and Neuroscience, Duke University, Durham, NC, USA.
Department of Psychiatry and Behavioral Sciences, Duke University Medical School, Durham, NC, USA.
Social, Genetic and Developmental Psychiatry Centre, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.

Louise Arseneault (L)

Social, Genetic and Developmental Psychiatry Centre, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.

France Gagnon (F)

Dalla Lana School of Public Health, University of Toronto, Toronto, Canada.

Miina Ollikainen (M)

Institute for Molecular Medicine, University of Helsinki, Helsinki, Finland.
Department of Public Health, Faculty of Medicine, University of Helsinki, Helsinki, Finland.

Jaakko Kaprio (J)

Institute for Molecular Medicine, University of Helsinki, Helsinki, Finland.
Department of Public Health, Faculty of Medicine, University of Helsinki, Helsinki, Finland.

Janine F Felix (JF)

The Generation R Study Group, Erasmus MC, University Medical Center Rotterdam, Rotterdam, the Netherlands.
Department of Pediatrics, Erasmus MC, University Medical Center Rotterdam, Rotterdam, the Netherlands.

Fernando Rivadeneira (F)

Department of Internal Medicine, Erasmus University Medical Center, Rotterdam, the Netherlands.

Henning Tiemeier (H)

Department of Child and Adolescent Psychiatry, Erasmus Medical Center, Rotterdam, the Netherlands.
Department of Social and Behavioral Science, Harvard TH Chan School of Public Health, Boston, MA, USA.

Marinus H van IJzendoorn (MH)

Department of Psychology, Education and Child Studies, Erasmus University Rotterdam, Rotterdam, the Netherlands.
Department of Clinical, Educational and Health Psychology, Division on Psychology and Language Sciences, Faculty of Brain Sciences, University College London, London, UK.

André G Uitterlinden (AG)

Department of Internal Medicine, Erasmus University Medical Center, Rotterdam, the Netherlands.

Vincent W V Jaddoe (VWV)

The Generation R Study Group, Erasmus MC, University Medical Center Rotterdam, Rotterdam, the Netherlands.
Department of Pediatrics, Erasmus MC, University Medical Center Rotterdam, Rotterdam, the Netherlands.

Chris Haley (C)

MRC Human Genetics Unit, Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh, UK.

Andrew M McIntosh (AM)

Division of Psychiatry, Royal Edinburgh Hospital, University of Edinburgh, Edinburgh, UK.
Centre for Cognitive Ageing and Cognitive Epidemiology, Department of Psychology, University of Edinburgh, Edinburgh, UK.

Kathryn L Evans (KL)

Centre for Genomic and Experimental Medicine, Institute of Genetics and Molecular Medicine, Western General Hospital, University of Edinburgh, Edinburgh, UK.
Centre for Cognitive Ageing and Cognitive Epidemiology, Department of Psychology, University of Edinburgh, Edinburgh, UK.

Alison Murray (A)

Institute of Medical Sciences, University of Aberdeen, Aberdeen, UK.

Katri Räikkönen (K)

Department of Psychology and Logopedics, Faculty of Medicine, University of Helsinki, Helsinki, Finland.

Jari Lahti (J)

Department of Psychology and Logopedics, Faculty of Medicine, University of Helsinki, Helsinki, Finland.

Ellen A Nohr (EA)

Research Unit for Gynaecology and Obstetrics, Institute of Clinical research, University of Southern Denmark, Odense, Denmark.
Centre of Women's, Family and Child Health, University of South-Eastern Norway, Kongsberg, Norway.

Thorkild I A Sørensen (TIA)

MRC Integrative Epidemiology Unit, University of Bristol, Bristol, UK.
Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK.
The Novo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
Department of Public Health (Section of Epidemiology), Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.

Torben Hansen (T)

The Novo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.

Camilla S Morgen (CS)

The Novo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
The National Institute of Public Health, University of Southern Denmark, Copenhagen, Denmark.

Elisabeth B Binder (EB)

Department of Translational Research in Psychiatry, Max-Planck-Institute of Psychiatry, Munich, Germany.
Department of Psychiatry and Behavioral Sciences, Emory University School of Medicine, Atlanta, GA, USA.

Susanne Lucae (S)

Department of Translational Research in Psychiatry, Max-Planck-Institute of Psychiatry, Munich, Germany.

Juan Ramon Gonzalez (JR)

ISGlobal, Barcelona Global Health Institute, Barcelona, Spain.
Universitat Pompeu Fabra, Barcelona, Spain.
CIBER Epidemiología y Salud Pública, Madrid, Spain.

Mariona Bustamante (M)

ISGlobal, Barcelona Global Health Institute, Barcelona, Spain.
Universitat Pompeu Fabra, Barcelona, Spain.
CIBER Epidemiología y Salud Pública, Madrid, Spain.
Center for Genomic Regulation, Barcelona Institute of Science and Technology, Barcelona, Spain.

Jordi Sunyer (J)

ISGlobal, Barcelona Global Health Institute, Barcelona, Spain.
Universitat Pompeu Fabra, Barcelona, Spain.
CIBER Epidemiología y Salud Pública, Madrid, Spain.
Hospital del Mar Medical Research Institute, Barcelona, Spain.

John W Holloway (JW)

Human Development and Health, Faculty of Medicine, University of Southampton, Southampton, UK.
Clinical and Experimental Sciences, Faculty of Medicine, University of Southampton, Southampton, UK.

Wilfried Karmaus (W)

Division of Epidemiology, Biostatistics, and Environmental Health Sciences, School of Public Health, University of Memphis, Memphis, TN, USA.

Hongmei Zhang (H)

Division of Epidemiology, Biostatistics, and Environmental Health Sciences, School of Public Health, University of Memphis, Memphis, TN, USA.

Ian J Deary (IJ)

Centre for Cognitive Ageing and Cognitive Epidemiology, Department of Psychology, University of Edinburgh, Edinburgh, UK.

Naomi R Wray (NR)

Institute for Molecular Bioscience, University of Queensland, Brisbane, Australia.
Queensland Brain Institute, University of Queensland, Brisbane, Australia.

John M Starr (JM)

Centre for Cognitive Ageing and Cognitive Epidemiology, Department of Psychology, University of Edinburgh, Edinburgh, UK.
Alzheimer Scotland Dementia Research Centre, University of Edinburgh, Edinburgh, UK.

Marian Beekman (M)

Molecular Epidemiology, Department of Biomedical Data Sciences, Leiden University Medical Center, Leiden, the Netherlands.

Diana van Heemst (D)

Department of Gerontology and Geriatrics, Leiden University Medical Center, Leiden, the Netherlands.

P Eline Slagboom (PE)

Molecular Epidemiology, Department of Biomedical Data Sciences, Leiden University Medical Center, Leiden, the Netherlands.

Pierre-Emmanuel Morange (PE)

C2VN, Aix-Marseille University, INSERM, INRAE, Marseille, France.

David-Alexandre Trégouët (DA)

INSERM UMR_S 1219, Bordeaux Population Health Center, University of Bordeaux, Bordeaux, France.

Jan H Veldink (JH)

Department of Neurology, Brain Center Rudolf Magnus, University Medical Center Utrecht, Utrecht, the Netherlands.

Gareth E Davies (GE)

Avera Institute for Human Genetics, Sioux Falls, SD, USA.

Eco J C de Geus (EJC)

Department of Biological Psychology, Amsterdam Public Health Research Institute, Vrije Universiteit Amsterdam, Amsterdam, the Netherlands.

Dorret I Boomsma (DI)

Department of Biological Psychology, Amsterdam Public Health Research Institute, Vrije Universiteit Amsterdam, Amsterdam, the Netherlands.

Judith M Vonk (JM)

University of Groningen, University Medical Center Groningen, Department of Epidemiology, GRIAC Research Institute Groningen, Groningen, the Netherlands.

Bert Brunekreef (B)

Institute for Risk Assessment Sciences, Universiteit Utrecht, Utrecht, the Netherlands.
Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, the Netherlands.

Gerard H Koppelman (GH)

University of Groningen, University Medical Center Groningen, Department of Pediatric Pulmonology and Pediatric Allergology, Beatrix Children's Hospital, GRIAC Research Institute Groningen, Groningen, the Netherlands.

Marta E Alarcón-Riquelme (ME)

Pfizer-University of Granada-Andalusian Government Center for Genomics and Oncological Research, Granada, Spain.
Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.

Rae-Chi Huang (RC)

Telethon Kids Institute, University of Western Australia, Perth, Australia.

Craig E Pennell (CE)

School of Medicine and Public Health, College of Health, Medicine and Wellbeing, University of Newcastle, Newcastle, Australia.

Joyce van Meurs (J)

Department of Internal Medicine, Erasmus University Medical Center, Rotterdam, the Netherlands.

M Arfan Ikram (MA)

Department of Epidemiology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, the Netherlands.

Alun D Hughes (AD)

UCL Institute of Cardiovascular Science, London, UK.

Therese Tillin (T)

UCL Institute of Cardiovascular Science, London, UK.

Nish Chaturvedi (N)

UCL Institute of Cardiovascular Science, London, UK.

Zdenka Pausova (Z)

The Hospital for Sick Children, University of Toronto, Toronto, Canada.

Tomas Paus (T)

Departments of Psychology and Psychiatry, University of Toronto, Toronto, Canada.

Timothy D Spector (TD)

Department of Twin Research and Genetic Epidemiology, King's College London, London, UK.

Meena Kumari (M)

Institute for Social and Economic Research, University of Essex, Colchester, UK.

Leonard C Schalkwyk (LC)

School of Life Sciences, University of Essex, Colchester, UK.

Peter M Visscher (PM)

Institute for Molecular Bioscience, University of Queensland, Brisbane, Australia.
Queensland Brain Institute, University of Queensland, Brisbane, Australia.

George Davey Smith (G)

MRC Integrative Epidemiology Unit, University of Bristol, Bristol, UK.
Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK.

Christoph Bock (C)

CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria.
Institute of Artificial Intelligence and Decision Support, Center for Medical Statistics, Informatics, and Intelligent Systems, Medical University of Vienna, Vienna, Austria.

Tom R Gaunt (TR)

MRC Integrative Epidemiology Unit, University of Bristol, Bristol, UK.
Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK.

Jordana T Bell (JT)

Department of Twin Research and Genetic Epidemiology, King's College London, London, UK.

Bastiaan T Heijmans (BT)

Molecular Epidemiology, Department of Biomedical Data Sciences, Leiden University Medical Center, Leiden, the Netherlands.

Jonathan Mill (J)

University of Exeter Medical School, College of Medicine and Health, University of Exeter, Exeter, UK.

Caroline L Relton (CL)

MRC Integrative Epidemiology Unit, University of Bristol, Bristol, UK.
Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH